feed,title,long_url,short_url
MarketWatch,ChemoCentryx's stock jumps 80% after receiving FDA approval for vasculitis drug,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/Dby9M_bbg3Y/story.aspx,https://on.mktw.net/3iF77gj
